ES2475721T3 - Síntesis de un piperazina neuroestimulante - Google Patents
Síntesis de un piperazina neuroestimulante Download PDFInfo
- Publication number
- ES2475721T3 ES2475721T3 ES10814260.5T ES10814260T ES2475721T3 ES 2475721 T3 ES2475721 T3 ES 2475721T3 ES 10814260 T ES10814260 T ES 10814260T ES 2475721 T3 ES2475721 T3 ES 2475721T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- compound
- alkyl
- reaction
- room temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23647709P | 2009-08-24 | 2009-08-24 | |
| US236477P | 2009-08-24 | ||
| PCT/US2010/046537 WO2011028548A1 (en) | 2009-08-24 | 2010-08-24 | Synthesis of a neurostimulative piperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2475721T3 true ES2475721T3 (es) | 2014-07-11 |
Family
ID=43649584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10814260.5T Active ES2475721T3 (es) | 2009-08-24 | 2010-08-24 | Síntesis de un piperazina neuroestimulante |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US9278933B2 (oth) |
| EP (1) | EP2470182B1 (oth) |
| JP (1) | JP5727482B2 (oth) |
| KR (1) | KR101701362B1 (oth) |
| CN (2) | CN102711764A (oth) |
| AU (1) | AU2010289802C1 (oth) |
| BR (1) | BR112012004161B1 (oth) |
| CA (1) | CA2772080C (oth) |
| CL (1) | CL2012000493A1 (oth) |
| DK (1) | DK2470182T3 (oth) |
| ES (1) | ES2475721T3 (oth) |
| HR (1) | HRP20140621T1 (oth) |
| IL (1) | IL218298A (oth) |
| IN (1) | IN2012DN02370A (oth) |
| MX (1) | MX2012002335A (oth) |
| NZ (1) | NZ598891A (oth) |
| PL (1) | PL2470182T3 (oth) |
| PT (1) | PT2470182E (oth) |
| RU (1) | RU2567390C2 (oth) |
| SG (1) | SG178867A1 (oth) |
| SI (1) | SI2470182T1 (oth) |
| WO (1) | WO2011028548A1 (oth) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2012DN02370A (oth) * | 2009-08-24 | 2015-08-21 | Neuralstem Inc | |
| JP7204640B2 (ja) * | 2016-09-12 | 2023-01-16 | ニューラルステム・インコーポレーテッド | 糖尿病に関連する神経障害の改善 |
| WO2018075667A1 (en) * | 2016-10-18 | 2018-04-26 | Neuralstem, Inc. | Amelioration of radiation-induced cognitive dysfunction |
| US10042957B2 (en) | 2017-01-12 | 2018-08-07 | Innovationdock, Inc. | Devices and methods for implementing dynamic collaborative workflow systems |
| US10413534B2 (en) * | 2017-02-13 | 2019-09-17 | Neuralstem, Inc. | Amelioration of certain deficiencies due to stroke |
| CN117377664A (zh) * | 2020-12-23 | 2024-01-09 | 贝勒医学院 | 孤儿核受体tlx的小分子调节剂 |
| EP4346823A2 (en) | 2021-06-03 | 2024-04-10 | Alto Neuroscience, Inc. | Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agent |
| US20240197721A1 (en) | 2022-12-05 | 2024-06-20 | Alto Neuroscience, Inc. | Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agent |
| US12208096B2 (en) | 2022-12-05 | 2025-01-28 | Alto Neuroscience, Inc. | Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent |
| US12233059B2 (en) | 2022-12-05 | 2025-02-25 | Alto Neuroscience, Inc. | Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agent |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU175075B (hu) * | 1977-06-30 | 1980-05-28 | Egyt Gyogyszervegyeszeti Gyar | Sposob poluchenija piperazidov piridin-karbonovoj kisloty |
| JPS54122283A (en) * | 1978-03-13 | 1979-09-21 | Sumitomo Chem Co Ltd | Novel quinazoline derivative and its preparation |
| US6995162B2 (en) * | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
| ES2335488T3 (es) | 2002-03-29 | 2010-03-29 | Schering Corporation | Alquilacion estereoselectiva de piperazinas quirales 2-metil-4-protegidas. |
| GB0222493D0 (en) * | 2002-09-27 | 2002-11-06 | Glaxo Group Ltd | Compounds |
| WO2004053071A2 (en) * | 2002-12-09 | 2004-06-24 | Judith Kelleher-Andersson | Method for discovering neurogenic agents |
| PT1663232E (pt) * | 2003-09-09 | 2007-12-12 | Hoffmann La Roche | Derivados de 1- (2-amino-benzol) -piperazina como inibidores de absorção de glicina para o tratamento de psicoses |
| BRPI0518068A (pt) * | 2004-10-29 | 2008-10-28 | Banyu Pharma Co Ltd | composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada |
| US7754724B2 (en) * | 2005-06-30 | 2010-07-13 | Dow Agrosciences Llc | N-substituted piperazines |
| RU2008129622A (ru) | 2005-12-20 | 2010-01-27 | Новартис АГ (CH) | Производные никотиновой кислоты в качестве модуляторов метаботропных глутаматных рецепторов |
| IN2012DN02370A (oth) * | 2009-08-24 | 2015-08-21 | Neuralstem Inc |
-
2010
- 2010-08-24 IN IN2370DEN2012 patent/IN2012DN02370A/en unknown
- 2010-08-24 ES ES10814260.5T patent/ES2475721T3/es active Active
- 2010-08-24 JP JP2012526928A patent/JP5727482B2/ja active Active
- 2010-08-24 US US13/392,489 patent/US9278933B2/en active Active
- 2010-08-24 SI SI201030669T patent/SI2470182T1/sl unknown
- 2010-08-24 RU RU2012111227/04A patent/RU2567390C2/ru not_active IP Right Cessation
- 2010-08-24 PL PL10814260T patent/PL2470182T3/pl unknown
- 2010-08-24 CN CN2010800465155A patent/CN102711764A/zh active Pending
- 2010-08-24 NZ NZ598891A patent/NZ598891A/en not_active IP Right Cessation
- 2010-08-24 AU AU2010289802A patent/AU2010289802C1/en active Active
- 2010-08-24 CN CN201511009541.1A patent/CN105693601A/zh active Pending
- 2010-08-24 PT PT108142605T patent/PT2470182E/pt unknown
- 2010-08-24 SG SG2012012878A patent/SG178867A1/en unknown
- 2010-08-24 CA CA2772080A patent/CA2772080C/en active Active
- 2010-08-24 BR BR112012004161A patent/BR112012004161B1/pt active IP Right Grant
- 2010-08-24 HR HRP20140621AT patent/HRP20140621T1/hr unknown
- 2010-08-24 MX MX2012002335A patent/MX2012002335A/es active IP Right Grant
- 2010-08-24 KR KR1020127007653A patent/KR101701362B1/ko active Active
- 2010-08-24 DK DK10814260.5T patent/DK2470182T3/da active
- 2010-08-24 EP EP10814260.5A patent/EP2470182B1/en active Active
- 2010-08-24 WO PCT/US2010/046537 patent/WO2011028548A1/en not_active Ceased
-
2012
- 2012-02-23 IL IL218298A patent/IL218298A/en active IP Right Grant
- 2012-02-24 CL CL2012000493A patent/CL2012000493A1/es unknown
-
2015
- 2015-12-09 US US14/964,397 patent/US9481649B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2475721T3 (es) | Síntesis de un piperazina neuroestimulante | |
| ES2705068T3 (es) | Síntesis química y cribado de bibliotecas de péptidos bicíclicos | |
| ES2341750B1 (es) | Compuestos de 3-amino-4-hidroxi-pirrolidinas sustituidos, su preparacion y uso como medicamentos. | |
| ES2659549T3 (es) | Sales cristalinas de Raltegravir sódico | |
| ES2657905T3 (es) | Inhibidores de BACE | |
| ES2670093T3 (es) | Antagonistas del receptor de P2X7 de tiazol u oxazol sustituidos | |
| KR102776189B1 (ko) | 발베나진의 고상 형태 | |
| ES2879294T3 (es) | Formas polimórficas de Belinostat y procesos para la preparación de las mismas | |
| MX2014012992A (es) | Derivado de quinazolindiona. | |
| CA3234823A1 (en) | A synthesis scheme and procedures for preparing a sik3 inhibitor and intermediates thereof | |
| BR112020008505A2 (pt) | compostos heterocíclicos anti-infecciosos e usos dos mesmos | |
| ES2962211T3 (es) | Proceso mejorado para preparar ozanimod | |
| CN103130787A (zh) | 嘧啶酮酰胺类化合物及其制备方法、抗hiv活性和抗tmv活性 | |
| WO2016127213A1 (en) | Inhibitors of necroptosis | |
| ES2203090T3 (es) | Procedimiento para la sintesis de inhibidores de proteasas del virus de la inmunodeficiencia humana. | |
| RU2349588C2 (ru) | Способы получения производных изотиазола | |
| ES2390767T3 (es) | Inhibidores de la péptido desformilasa | |
| KR101630243B1 (ko) | 신규한 화합물, 이의 약학적으로 허용가능한 염 또는 이의 광학 이성질체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물 | |
| Wang et al. | Synthesis and evaluation of unsaturated caprolactams as interleukin-1β converting enzyme (ICE) inhibitors | |
| ES2861050T3 (es) | Procedimiento de producción de derivado de tiazol | |
| ES2992926T3 (en) | Process for the preparation of a substituted imidazoquinoline | |
| JP6325139B2 (ja) | カルムスチンの安全で効率的な製造方法 | |
| CA3223875A1 (en) | Heterocycloalkyl-substituted polyheteroazole derivatives as medicaments for treating and/or preventing rs virus infections | |
| HK1172844B (en) | Synthesis of a neurostimulative piperazine | |
| US3228962A (en) | N-(2, 2-pentamethylene pyrrolidino methyl) tetracycline and salts |